title: Does dabigatran interfere with intraablation heparinization?
authors.affiliation: Department of Cardiology, Graduate School of Medicine, Hiroshima University, Hiroshima, Japan. Electronic address: rjrgw059@ybb.ne.jp.
authors.forename: Akinori
authors.initials: A
authors.lastname: Sairaku
authors.affiliation: Department of Cardiology, Graduate School of Medicine, Hiroshima University, Hiroshima, Japan.
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Nakano
authors.affiliation: Department of Cardiology, Graduate School of Medicine, Hiroshima University, Hiroshima, Japan.
authors.forename: Yasuki
authors.initials: Y
authors.lastname: Kihara
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D000991:Antithrombins / Q000008:administration & dosage* / Q000009:adverse effects; D001281:Atrial Fibrillation / Q000097:blood / Q000150:complications / Q000601:surgery*; D001777:Blood Coagulation / Q000187:drug effects*; D017115:Catheter Ablation / Q000009:adverse effects; D000069604:Dabigatran / Q000008:administration & dosage* / Q000009:adverse effects; D006493:Heparin / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D012307:Risk Factors; D020521:Stroke / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D016896:Treatment Outcome; D014859:Warfarin / Q000008:administration & dosage; D014914:Whole Blood Coagulation Time
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D014859:Warfarin; D006493:Heparin; D000069604:Dabigatran